Skip to main content
AAN.com

Abstract

Background: In 2000, the Brain Attack Coalition (BAC) recommended 11 major criteria for the establishment of primary stroke centers. The BAC relied heavily on expert opinion because evidence supporting the criteria was sparse.
Objective: To assess primary stroke center elements, based on the criteria proposed by the BAC, with a questionnaire at 34 academic medical centers.
Methods: Patient characteristics and outcomes were collected for all patients (n = 16,853) admitted with ischemic stroke to each hospital from 1999 to 2001. Stroke center elements were evaluated as predictors of treatment with tissue plasminogen activator (tPA) and outcomes after adjustment for patient characteristics.
Results: The in-hospital mortality rate was 6.3% (n = 1,062), and 2.4% (n = 399) of patients received tPA. None of the 11 major stroke center elements was associated with decreased in-hospital mortality or increased frequency of discharge home. However, four elements predicted increased tPA use, including written care protocols, integrated emergency medical services, organized emergency departments, and continuing medical/public education in stroke (each odds ratio [OR] > 2.0, p < 0.05). Use of tPA also tended to be greater at centers with an acute stroke team, a stroke unit, or rapid neuroimaging (each OR > 2.0, p < 0.10). Institutions with a greater number of major stroke center elements used tPA more frequently.
Conclusions: Of the 11 stroke center elements recommended by the BAC, 7 were associated with increased tPA use. Institutions with a greater number of these seven features used tPA more often, suggesting these key elements may be most important for primary stroke center designation, at least in terms of identifying centers that deliver IV tPA frequently.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)
File (e2.doc)
File (e3.doc)
File (e4.doc)

References

1.
Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102–3109.
2.
Joint Commission on Accreditation of Healthcare Organizations. Primary Stroke Centers. Available at: http://www.jcaho.org/dscc/psc/index.htm; accessed July 13, 2004.
3.
Kidwell CS, Shephard T, Tonn S, et al. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources. Neurology 2003;60:1452–1456.
4.
Adams R, Acker J, Alberts M, et al. Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options. Stroke 2002;33:E1–E7.
5.
Bowen J, Yaste C. Effect of a stroke protocol on hospital costs of stroke patients. Neurology 1994;44:1961–1964.
6.
Newell SD Jr, Englert J, Box-Taylor A, Davis KM, Koch KE. Clinical efficiency tools improve stroke management in a rural southern health system. Stroke 1998;29:1092–1098.
7.
Webb DJ, Fayad PB, Wilbur C, Thomas A, Brass LM. Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program. Stroke 1995;26:1353–1357.
8.
Wentworth DA, Atkinson RP. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke 1996;27:1040–1043.
9.
Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). Oxford, UK: Cochrane Library, update software; 2003, issue 1.
10.
Stroke Unit Trialists Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997;28:2139–2144.
11.
Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke: outcomes, patient mix, and practice variation for neurologists and generalists in a community. Neurology 1998;50:1669–1678.
12.
Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke 1996;27:1937–1943.
13.
Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke 1995;26:249–253.
14.
Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003;61:792–796.
15.
Lattimore SU, Chalela J, Davis L, et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS suburban hospital stroke center experience. Stroke 2003;34:E55–E57.
16.
Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003;34:799–800.
17.
Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke 2002;33:160–166.
18.
Gillum LA, Johnston SC. Characteristics of academic medical centers and ischemic stroke outcomes. Stroke 2001;32:2137–2142.
19.
University Health System Consortium. Member statistics. Available at: http://www.uhc.edu/about/memstats.html; accessed May 20, 2003.
20.
Ellekjaer H, Holmen J, Kruger O, Terent A. Identification of incident stroke in Norway: hospital discharge data compared with a population-based stroke register. Stroke 1999;30:56–60.
21.
Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998;29:1602–1604.
22.
Leibson CL, Naessens JM, Brown RD, Whisnant JP. Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348–2355.
23.
Johnston SC, Fung LH, Gillum LA, et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001;32:1061–1068.
24.
Johnston SC. Combining ecological and individual variables to reduce confounding by indication: case study–subarachnoid hemorrhage treatment. J Clin Epidemiol 2000;53:1236–1241.
25.
Johnston SC, Henneman T, McCulloch CE, van der Laan M. Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. Am J Epidemiol 2002;156:753–760.
26.
Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford, UK: Clarendon Press, 1994.
27.
Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York: Wiley, 1999.
28.
Burgin WS, Staub L, Chan W, et al. Acute stroke care in non-urban emergency departments. Neurology 2001;57:2006–2012.
29.
Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG, Wang DZ. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832–1840.
30.
Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015–1020.
31.
Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63–69.
32.
Hill MD, Barber PA, Demchuk AM, et al. Building a “brain attack” team to administer thrombolytic therapy for acute ischemic stroke. Can Med Assoc J 2000;162:1589–1593.
33.
Riopelle RJ, Howse DC, Bolton C, et al. Regional access to acute ischemic stroke intervention. Stroke 2001;32:652–655.
34.
Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23:352–356.
35.
Behrens S, Daffertshofer M, Interthal C, Ellinger K, van Ackern K, Hennerici M. Improvement in stroke quality management by an educational programme. Cerebrovasc Dis 2002;13:262–266.
36.
Pell AC, Miller HC, Robertson CE, Fox KA. Effect of “fast track” admission for acute myocardial infarction on delay to thrombolysis. Br Med J 1992;304:83–87.
37.
Bonetti PO, Waeckerlin A, Schuepfer G, Frutiger A. Improving time-sensitive processes in the intensive care unit: the example of “door-to-needle time” in acute myocardial infarction. Int J Qual Health Care 2000;12:311–317.
38.
Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston, Texas. Stroke 1995;26:409–414.
39.
Gomez CR, Malkoff MD, Sauer CM, Tulyapronchote R, Burch CM, Banet GA. Code stroke. An attempt to shorten inhospital therapeutic delays. Stroke 1994;25:1920–1923.
40.
Lambrew CT, Bowlby LJ, Rogers WJ, Chandra NC, Weaver WD. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. Arch Intern Med 1997;157:2577–2582.
41.
Evans A, Perez I, Harraf F, et al. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 2001;358:1586–1592.
42.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
43.
Lai SM, Alter M, Friday G, Lai SL, Sobel E. Disposition after acute stroke: who is not sent home from hospital? Neuroepidemiology 1998;17:21–29.
44.
Goldstein LB, Hey LA, Laney R. North Carolina Stroke Prevention and Treatment Facilities Survey. Statewide availability of programs and services. Stroke 2000;31:66–70.

Information & Authors

Information

Published In

Neurology®
Volume 64Number 3February 8, 2005
Pages: 422-427
PubMed: 15699369

Publication History

Published online: February 7, 2005
Published in print: February 8, 2005

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

V. C. Douglas, MD
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
D. C. Tong, MD
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
L. A. Gillum, MD, MPH
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
S. Zhao, MD, PhD
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
L. M. Brass, MD
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
J. Dostal, BSID, IE, MBA
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.
S. C. Johnston, MD, PhD
From the Department of Neurology (Drs. Douglas, Gillum, Zhao, and Johnston), University of California, San Francisco, Department of Neurology (Dr. Tong), Stanford University Medical Center, CA, Department of Neurology (Dr. Brass), Yale University Medical School, New Haven, CT, and University HealthSystem Consortium (J. Dostal), Oak Brook, IL.

Notes

Address correspondence and reprint requests to Dr. S.C. Johnston, Department of Neurology, Box 0114, University of California, San Francisco, 505 Parnassus Ave., M-798, San Francisco, CA 94143-0114; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Length of Hospitalization and Mortality among Stroke Patients before and after the Implementation of a Specialized Unit: A Retrospective Cohort Study Using Real-World Data from One Reference Hospital in Southern Brazil, Healthcare, 12, 8, (836), (2024).https://doi.org/10.3390/healthcare12080836
    Crossref
  2. GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance, Stroke and Vascular Neurology, 6, 3, (337-343), (2021).https://doi.org/10.1136/svn-2020-000633
    Crossref
  3. Quality of Acute Stroke Care at Primary Stroke Centers Before and After Certification in Comparison to Never-Certified Hospitals, Frontiers in Neurology, 10, (2020).https://doi.org/10.3389/fneur.2019.01396
    Crossref
  4. Acute ischemic stroke: improving access to intravenous tissue plasminogen activator, Expert Review of Cardiovascular Therapy, 18, 5, (277-287), (2020).https://doi.org/10.1080/14779072.2020.1759422
    Crossref
  5. Tokyo Metropolitan Stroke Emergency Medical Services for Interventional Stroke Treatment: The Tama-REgistry of Acute Thrombectomy (TREAT) Study, Journal of Stroke and Cerebrovascular Diseases, 29, 6, (104752), (2020).https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104752
    Crossref
  6. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke, 50, 12, (2019).https://doi.org/10.1161/STR.0000000000000211
    Crossref
  7. Modelling care quality for patients after a transient ischaemic attack within the US Veterans Health Administration, BMJ Open Quality, 8, 4, (e000641), (2019).https://doi.org/10.1136/bmjoq-2019-000641
    Crossref
  8. Effect of Acute Stroke Care Regionalization on Intravenous Alteplase Use in Two Urban Counties, Prehospital Emergency Care, 24, 4, (505-514), (2019).https://doi.org/10.1080/10903127.2019.1679303
    Crossref
  9. 2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: A proposal to optimize care for patients with valvular heart disease, The Journal of Thoracic and Cardiovascular Surgery, 157, 6, (e327-e354), (2019).https://doi.org/10.1016/j.jtcvs.2019.03.004
    Crossref
  10. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease, Journal of the American College of Cardiology, 73, 20, (2609-2635), (2019).https://doi.org/10.1016/j.jacc.2018.10.007
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share